GGrantIndex
Sort

326,823 grants matching clinical trial

Imperial County Clinical Research Network

$2,323,771
Guadalupe X Ayala · San Diego State University · UH3 · FY2025 · MD

Pro-inflammatory cytokine lowering anti-inflammatory drugs

$2,323,536
Nigel H. Greig · National Institute On Aging · ZIA · FY2024 · AG

SPORE in Breast Cancer

$2,323,522
Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2019 · CA

Clinical trials to prevent Alzheimer's Disease in Down Syndrome

$2,323,427
Michael S Rafii · University Of Southern California · R61 · FY2019 · AG

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,323,304
Gary E Rosenthal · University Of Iowa · UL1 · FY2011 · RR

Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium

$2,322,833
Vernon M. Chinchilli · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2020 · DK

Cardiac Gene Transfer of AC & Mechanisms for Effects

$2,322,757
H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2009 · HL

Brain Tumor SPORE Grant

$2,322,633
Mitchel S. Berger · University Of California, San Francisco · P50 · FY2019 · CA

Immune Reconstitution

$2,322,567
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

SOUTHWEST ONCOLOGY GROUP--OPERATIONS OFFICER

$2,322,397
Cancer Therapy And Research Center · U10 · FY2004 · CA

Novel Therapies to Improve Renal and Cardiac Allograft Outcomes

$2,322,378
Mohamed H Sayegh · Brigham And Women'S Hospital · U01 · FY2009 · AI

Clinic, Family & Community Collaboration to Treat Overweight and Obese Children

$2,322,319
Thomas N Robinson · Stanford University · U01 · FY2012 · HL

SPORE in Brain Cancer

$2,322,240
Darell D Bigner · Duke University · P50 · FY2007 · CA

UCLA Los Angeles Brazil AIDS Consortium

$2,322,195
Yvonne J Bryson · University Of California Los Angeles · U01 · FY2007 · AI

Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial

$2,322,084
Merit E Cudkowicz · Massachusetts General Hospital · U01 · FY2017 · NS

Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine

$2,321,982
Louis J. Picker · Oregon Health & Science University · U19 · FY2020 · AI

Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine

$2,321,982
Louis J. Picker · Oregon Health & Science University · U19 · FY2019 · AI

Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine

$2,321,981
Louis J. Picker · Oregon Health & Science University · U19 · FY2021 · AI

Neuroprotection Studies in PD: A Coordinating Center

$2,321,905
Karl D. Kieburtz · University Of Rochester · U01 · FY2011 · NS

CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE

$2,321,712
Christina Wang · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · N01 · FY2022 · HD

The Alliance NCTN Biorepository and Biospecimen Resource

$2,321,116
Mark A Watson · Washington University · U24 · FY2020 · CA

Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease

$2,320,945
William T Dauer · University Of Michigan At Ann Arbor · P50 · FY2014 · NS

UCSF PROSTATE CANCER SPORE

$2,320,920
University Of California San Francisco · P50 · FY2001 · CA

Phase 1 Clinical Trial: Carbapenem-resistant Enterbacterales (CRE)

$2,320,888
Graig Shockey · Dynport Vaccine Company, Llc · N01 · FY2022 · AI

Stem Cell Biology: New Directions in Clinical and Basic Research

$2,320,339
Peter J Quesenberry · Rhode Island Hospital · P20 · FY2010 · RR